Invesco’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.57M | Buy |
434,753
+1,463
| +0.3% | +$18.6K | ﹤0.01% | 2146 |
|
|
2025
Q4 | $3.9M | Buy |
433,290
+23,870
| +6% | +$329K | ﹤0.01% | 2358 |
|
|
2025
Q3 | $7.07M | Buy |
409,420
+157,844
| +63% | +$1.94M | ﹤0.01% | 2043 |
|
|
2025
Q2 | $2.36M | Buy |
251,576
+80,401
| +47% | +$660K | ﹤0.01% | 2514 |
|
|
2025
Q1 | $1.22M | Buy |
171,175
+74,741
| +78% | +$755K | ﹤0.01% | 2745 |
|
|
2024
Q4 | $1.12M | Buy |
96,434
+3,677
| +4% | +$57.4K | ﹤0.01% | 2870 |
|
|
2024
Q3 | $1.91M | Sell |
92,757
-3,273
| -3% | -$75.5K | ﹤0.01% | 2623 |
|
|
2024
Q2 | $2.15M | Sell |
96,030
-665
| -0.7% | -$15.8K | ﹤0.01% | 2554 |
|
|
2024
Q1 | $2.66M | Buy |
96,695
+24,051
| +33% | +$668K | ﹤0.01% | 2539 |
|
|
2023
Q4 | $2.21M | Buy |
72,644
+6,742
| +10% | +$194K | ﹤0.01% | 2575 |
|
|
2023
Q3 | $2.08M | Buy |
65,902
+40
| +0.1% | +$1.55K | ﹤0.01% | 2579 |
|
|
2023
Q2 | $2.69M | Sell |
65,862
-6,658
| -9% | -$270K | ﹤0.01% | 2537 |
|
|
2023
Q1 | $2.7M | Sell |
72,520
-345,358
| -83% | -$13.5M | ﹤0.01% | 2515 |
|
|
2022
Q4 | $14.6M | Buy |
417,878
+13,299
| +3% | +$632K | ﹤0.01% | 1562 |
|
|
2022
Q3 | $22.6M | Buy |
404,579
+8,239
| +2% | +$511K | 0.01% | 1247 |
|
|
2022
Q2 | $20.5M | Buy |
396,340
+7,659
| +2% | +$389K | 0.01% | 1358 |
|
|
2022
Q1 | $28.2M | Sell |
388,681
-88,724
| -19% | -$7.52M | 0.01% | 1280 |
|
|
2021
Q4 | $56.4M | Sell |
477,405
-193,791
| -29% | -$24.3M | 0.01% | 996 |
|
|
2021
Q3 | $90M | Sell |
671,196
-13,435
| -2% | -$2.03M | 0.02% | 842 |
|
|
2021
Q2 | $111M | Sell |
684,631
-546,933
| -44% | -$42.6M | 0.03% | 789 |
|
|
2021
Q1 | $98.8M | Sell |
1,231,564
-259,385
| -17% | -$17.4M | 0.03% | 812 |
|
|
2020
Q4 | $81.1M | Buy |
1,490,949
+1,174,248
| +371% | +$42.6M | 0.02% | 823 |
|
|
2020
Q3 | $6.3M | Buy |
316,701
+269,294
| +568% | +$5.62M | ﹤0.01% | 1893 |
|
|
2020
Q2 | $996K | Buy |
47,407
+27,485
| +138% | +$467K | ﹤0.01% | 2802 |
|
|
2020
Q1 | $244K | Buy |
19,922
+2,034
| +11% | +$27.4K | ﹤0.01% | 3338 |
|
|
2019
Q4 | $262K | Sell |
17,888
-1,175
| -6% | -$16.3K | ﹤0.01% | 3464 |
|
|
2019
Q3 | $254K | Sell |
19,063
-744
| -4% | -$11.9K | ﹤0.01% | 3480 |
|
|
2019
Q2 | $324K | Sell |
19,807
-675
| -3% | -$10.6K | ﹤0.01% | 3475 |
|
|
2019
Q1 | $350K | Buy |
+20,482
| New | +$305K | ﹤0.01% | 3437 |
|
|
2018
Q2 | – | Sell |
-268,551
| Closed | -$5.66M | – | 3904 |
|
|
2018
Q1 | $5.66M | Buy |
+268,551
| New | +$6.6M | ﹤0.01% | 1882 |
|
|
2016
Q4 | – | Sell |
-82,974
| Closed | -$1.41M | – | 3698 |
|
|
2016
Q3 | $1.41M | Sell |
82,974
-20
| -0% | -$387 | ﹤0.01% | 2770 |
|
|
2016
Q2 | $1.77M | Buy |
+82,994
| New | +$2.21M | ﹤0.01% | 2546 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
